Best Corona Virus Play

AERIS

Real company with a suite of products in the form Residual Surface Protection proven against the Corona Virus as well as Air Conditioner treatment,Disinfectants amongst other things..

Comparisons against other players has AEI streaks ahead

Market Cap Revenue

AEI $120m $20m+(committed)

ZNO $275m $18m
(Reported)

FOD $70m $7m (estimated)

HCT $50m $7m (reported)

NOTE - that AEI has the highest margin of comparable companies @ 55% hinting at a profitable Quarter and beyond.

The Company sells disinfection products that have been approved by the Chinese National Health Commission.

These products are attracting significant demand due to the current coronavirus outbreak in China.

In order to meet this demand for disinfectants, particularly in China, Aeris has been scaling significantly and has increased its production capacity.

Aeris is working closely with authorities in the region to provide technical support, advice and products to assist with the containment of the current epidemic.

Aeris is currently scaling up production, redirecting its manufacturing capacity, in the near term, to multiple Australian manufacturing sites.

This is to support the needs of its customers, and the growing demand in China and the APAC region.

Aeris Active contains a ‘dual active’ biocide system, providing broad spectrum viricidal, bactericidal and fungicidal efficacy together with proprietary ‘residual protection’ affording, in addition to the initial kill, long-term (200 touch or seven day) protection of at-risk surfaces.